Cargando…

A New Model for Predicting Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma

OBJECTIVES: To develop a model that can predict the risk of hypothyroidism (HT) after intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma (NPC), and to accordingly recommend dose constraints. MATERIALS AND METHODS: NPC patients treated between 2011 and 2015 were retrospectively revi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peng, Liang, Mao, Yan-Ping, Huang, Cheng-Long, Guo, Rui, Ma, Jun, Wen, Wei-Ping, Tang, Ling-Long
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546200/ https://www.ncbi.nlm.nih.gov/pubmed/33102218 http://dx.doi.org/10.3389/fonc.2020.551255

Ejemplares similares

Thyroid dose‐volume thresholds for the risk of radiation‐related hypothyroidism in nasopharyngeal carcinoma treated with intensity‐modulated radiotherapy—A single‐institution study
por: Huang, Cheng‐Long, et al.
Publicado: (2019)

Multivariate NTCP Model of Hypothyroidism After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Shen, Guanzhu, et al.
Publicado: (2021)

Patterns and prognosis of regional recurrence in nasopharyngeal carcinoma after intensity‐modulated radiotherapy
por: Xiao, Xiao‐Tang, et al.
Publicado: (2022)

The Effect of Prolonged Duration of Intensity Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Hua, Yi-Jun, et al.
Publicado: (2021)

A Nomogram Based on Serum Biomarkers and Clinical Characteristics to Predict Survival in Patients With Non-Metastatic Nasopharyngeal Carcinoma
por: Li, Qing-Jie, et al.
Publicado: (2020)

Incidence of and Risk Factors for Mastoiditis after Intensity Modulated Radiotherapy in Nasopharyngeal Carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

The development and external validation of simplified T category classification for nasopharyngeal carcinoma to improve the prognostic value in the intensity‐modulated radiotherapy era
por: Tang, Ling‐Long, et al.
Publicado: (2019)

Circulating EBV DNA, Globulin and Nodal Size Predict Distant Metastasis after Intensity-Modulated Radiotherapy in Stage II Nasopharyngeal Carcinoma
por: Du, Xiao-Jing, et al.
Publicado: (2016)

Prognostic value of wait time in nasopharyngeal carcinoma treated with intensity modulated radiotherapy: a propensitymatched analysis
por: Chen, Yu-Pei, et al.
Publicado: (2016)

Analysis of simultaneous modulated accelerated radiotherapy (SMART) for nasopharyngeal carcinomas
por: Tang, Jian Min, et al.
Publicado: (2014)

Dose-volume factors associated with ear disorders following intensity modulated radiotherapy in nasopharyngeal carcinoma
por: Yao, Ji-Jin, et al.
Publicado: (2015)

Outcomes of patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Yeh, Shyh-An, et al.
Publicado: (2021)

Second Primary Lung Adenocarcinoma After Intensity-Modulated Radiotherapy for Nasopharyngeal Carcinoma
por: Xue, Fen, et al.
Publicado: (2022)

Evaluation of the National Comprehensive Cancer Network and European Society for Medical Oncology Nasopharyngeal Carcinoma Surveillance Guidelines
por: Zhou, Guan-Qun, et al.
Publicado: (2020)

Prognostic factors and failure patterns in non-metastatic nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Mao, Yan-Ping, et al.
Publicado: (2016)

Predictors of radiation-induced hypothyroidism in nasopharyngeal carcinoma survivors after intensity-modulated radiotherapy
por: Zhai, Ruiping, et al.
Publicado: (2022)

The Long-Term Recovery of Parotid Glands in Nasopharyngeal Carcinoma Treated by Intensity-Modulated Radiotherapy
por: Tasaka, Shun, et al.
Publicado: (2021)

Prognostic scoring system for locoregional control among the patients with nasopharyngeal carcinoma treated by intensity-modulated radiotherapy
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Investigation of the feasibility of elective irradiation to neck level Ib using intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma: a retrospective analysis
por: Zhang, Fan, et al.
Publicado: (2015)

Significant value of (18)F-FDG-PET/CT in diagnosing small cervical lymph node metastases in patients with nasopharyngeal carcinoma treated with intensity-modulated radiotherapy
por: Peng, Hao, et al.
Publicado: (2017)

Half-Brain Delineation for Prediction of Radiation-Induced Temporal Lobe Injury in Nasopharyngeal Carcinoma Receiving Intensity-Modulated Radiotherapy
por: Du, Qing-Hua, et al.
Publicado: (2021)

Prognostic value of parotid lymph node metastasis in patients with nasopharyngeal carcinoma receiving intensity-modulated radiotherapy
por: Zhang, Yuan, et al.
Publicado: (2015)

Nomogram Predicting the Benefits of Adding Concurrent Chemotherapy to Intensity-Modulated Radiotherapy After Induction Chemotherapy in Stages II–IVb Nasopharyngeal Carcinoma
por: Liu, Sai-Lan, et al.
Publicado: (2020)

Prognostic nomogram of xerostomia for patients with nasopharyngeal carcinoma after intensity-modulated radiotherapy
por: Pan, Xin-Bin, et al.
Publicado: (2020)

Intensive Local Radiotherapy Is Associated With Better Local Control and Prolonged Survival in Bone-Metastatic Nasopharyngeal Carcinoma Patients
por: Li, Xiao-Yun, et al.
Publicado: (2020)

Long-term outcome and late toxicities of simultaneous integrated boost-intensity modulated radiotherapy in pediatric and adolescent nasopharyngeal carcinoma
por: Tao, Chang-Juan, et al.
Publicado: (2013)

Assessment of anatomical and dosimetric changes by a deformable registration method during the course of intensity-modulated radiotherapy for nasopharyngeal carcinoma
por: Lu, Jie, et al.
Publicado: (2014)

Comparison of the efficacy between intensity-modulated radiotherapy and two-dimensional conventional radiotherapy in stage II nasopharyngeal carcinoma
por: Pan, Xin-Bin, et al.
Publicado: (2017)

Neoadjuvant and Concurrent Chemotherapy Have Varied Impacts on the Prognosis of Patients with the Ascending and Descending Types of Nasopharyngeal Carcinoma Treated with Intensity-Modulated Radiotherapy
por: Yao, Ji-Jin, et al.
Publicado: (2016)

Clinical Implications of Plasma Epstein–Barr Virus DNA in Children and Adolescent Nasopharyngeal Carcinoma Patients Receiving Intensity-Modulated Radiotherapy
por: Qiu, Wenze, et al.
Publicado: (2020)

Patient- and treatment-related risk factors associated with neck muscle spasm in nasopharyngeal carcinoma patients after intensity-modulated radiotherapy
por: Zhang, Lu-Lu, et al.
Publicado: (2017)

Should All Nasopharyngeal Carcinoma with Paranasal Sinus Invasion Be Staged as T3 in the Intensity-Modulated Radiotherapy Era? A Study of 1811 Cases
por: Zhang, Yuan, et al.
Publicado: (2016)

Prognostic Value and Staging Classification of Retropharyngeal Lymph Node Metastasis in Nasopharyngeal Carcinoma Patients Treated with Intensity-modulated Radiotherapy
por: Tang, Ling-Long, et al.
Publicado: (2014)

Comparing the Effectiveness of Endoscopic Surgeries With Intensity-Modulated Radiotherapy for Recurrent rT3 and rT4 Nasopharyngeal Carcinoma: A Meta-Analysis
por: Peng, Zhouying, et al.
Publicado: (2021)

Analysis of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma
por: Wu, Shihai, et al.
Publicado: (2020)

Induction Chemotherapy Combined With Intensity-Modulated Radiotherapy for 129 Nasopharyngeal Carcinoma Patients With Synchronous Metastases: A Retrospective Study
por: Ni, Mengshan, et al.
Publicado: (2021)

Radiation-Induced Temporal Lobe Injury for Nasopharyngeal Carcinoma: A Comparison of Intensity-Modulated Radiotherapy and Conventional Two-Dimensional Radiotherapy
por: Zhou, Guan-Qun, et al.
Publicado: (2013)

Neoadjuvant chemotherapy in locally advanced nasopharyngeal carcinoma: Defining high-risk patients who may benefit before concurrent chemotherapy combined with intensity-modulated radiotherapy
por: Du, Xiao-Jing, et al.
Publicado: (2015)

Selection and Validation of Induction Chemotherapy Beneficiaries Among Patients With T3N0, T3N1, T4N0 Nasopharyngeal Carcinoma Using Epstein-Barr Virus DNA: A Joint Analysis of Real-World and Clinical Trial Data
por: Xu, Cheng, et al.
Publicado: (2019)

Experience with combination of nimotuzumab and intensity-modulated radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma
por: Zhai, Rui-ping, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_gmtbjl434uu5i0nl0tj62kolr6